Cd133: a marker of transit amplification rather than stem cell phenotype in the prostate?
AffiliationGenito-Urinary Cancer Research Group, University of Manchester Paterson Institute for Cancer Research, Manchester, UK. firstname.lastname@example.org
MetadataShow full item record
CitationCd133: a marker of transit amplification rather than stem cell phenotype in the prostate? 2009, 103 (7):856-8 BJU Int.
- CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
- Authors: Yamamoto H, Masters JR, Dasgupta P, Chandra A, Popert R, Freeman A, Ahmed A
- Issue date: 2012
- Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
- Authors: Rentala S, Mangamoori LN
- Issue date: 2010
- Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance.
- Authors: Montgomery RK, Shivdasani RA
- Issue date: 2009 Jun
- Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
- Authors: Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C
- Issue date: 2011 Sep 14
- A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
- Authors: Choi SA, Wang KC, Phi JH, Lee JY, Park CK, Park SH, Kim SK
- Issue date: 2012 Nov 28